Spain · Delayed Price · Currency is EUR BME:ACS Statistics
Total Valuation
BME:ACS has a market cap or net worth of EUR 24.21 billion. The enterprise value is 27.02 billion.
| Market Cap | 24.21B |
| Enterprise Value | 27.02B |
Important Dates
The last earnings date was Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
BME:ACS has 265.94 million shares outstanding. The number of shares has increased by 1.63% in one year.
| Current Share Class | 265.94M |
| Shares Outstanding | 265.94M |
| Shares Change (YoY) | +1.63% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 18.43% |
| Float | 176.96M |
Valuation Ratios
The trailing PE ratio is 21.90 and the forward PE ratio is 19.35. BME:ACS's PEG ratio is 1.04.
| PE Ratio | 21.90 |
| Forward PE | 19.35 |
| PS Ratio | 0.45 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 41.40 |
| P/FCF Ratio | 9.88 |
| P/OCF Ratio | 7.60 |
| PEG Ratio | 1.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.09, with an EV/FCF ratio of 11.01.
| EV / Earnings | 25.15 |
| EV / Sales | 0.50 |
| EV / EBITDA | 9.09 |
| EV / EBIT | 13.69 |
| EV / FCF | 11.01 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 2.42.
| Current Ratio | 1.42 |
| Quick Ratio | 1.12 |
| Debt / Equity | 2.42 |
| Debt / EBITDA | 5.21 |
| Debt / FCF | 5.82 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 25.01% and return on invested capital (ROIC) is 15.94%.
| Return on Equity (ROE) | 25.01% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 15.94% |
| Return on Capital Employed (ROCE) | 8.22% |
| Weighted Average Cost of Capital (WACC) | 6.21% |
| Revenue Per Employee | 356,905 |
| Profits Per Employee | 7,120 |
| Employee Count | 152,300 |
| Asset Turnover | 1.83 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:ACS has paid 606.87 million in taxes.
| Income Tax | 606.87M |
| Effective Tax Rate | 30.81% |
Stock Price Statistics
The stock price has increased by +15.55% in the last 52 weeks. The beta is 0.63, so BME:ACS's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +15.55% |
| 50-Day Moving Average | 92.41 |
| 200-Day Moving Average | 109.52 |
| Relative Strength Index (RSI) | 50.06 |
| Average Volume (20 Days) | 429,864 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:ACS had revenue of EUR 54.36 billion and earned 1.08 billion in profits. Earnings per share was 4.16.
| Revenue | 54.36B |
| Gross Profit | 20.11B |
| Operating Income | 1.76B |
| Pretax Income | 1.97B |
| Net Income | 1.08B |
| EBITDA | 2.46B |
| EBIT | 1.76B |
| Earnings Per Share (EPS) | 4.16 |
Balance Sheet
The company has 11.92 billion in cash and 14.43 billion in debt, with a net cash position of -2.51 billion or -9.44 per share.
| Cash & Cash Equivalents | 11.92B |
| Total Debt | 14.43B |
| Net Cash | -2.51B |
| Net Cash Per Share | -9.44 |
| Equity (Book Value) | 5.95B |
| Book Value Per Share | 21.70 |
| Working Capital | 4.47B |
Cash Flow
In the last 12 months, operating cash flow was 3.22 billion and capital expenditures -743.76 million, giving a free cash flow of 2.48 billion.
| Operating Cash Flow | 3.22B |
| Capital Expenditures | -743.76M |
| Depreciation & Amortization | 698.51M |
| Net Borrowing | 550.03M |
| Free Cash Flow | 2.48B |
| FCF Per Share | 9.31 |
Margins
Gross margin is 36.99%, with operating and profit margins of 3.24% and 1.99%.
| Gross Margin | 36.99% |
| Operating Margin | 3.24% |
| Pretax Margin | 3.62% |
| Profit Margin | 1.99% |
| EBITDA Margin | 4.52% |
| EBIT Margin | 3.24% |
| FCF Margin | 4.56% |
Dividends & Yields
This stock pays an annual dividend of 2.32, which amounts to a dividend yield of 2.55%.
| Dividend Per Share | 2.32 |
| Dividend Yield | 2.55% |
| Dividend Growth (YoY) | 15.51% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 40.26% |
| FCF Payout Ratio | 24.94% |
| Buyback Yield | -1.63% |
| Shareholder Yield | 0.90% |
| Earnings Yield | 4.57% |
| FCF Yield | 10.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for BME:ACS is 128.53, which is 41.16% higher than the current price. The consensus rating is "Buy".
| Price Target | 128.53 |
| Price Target Difference | 41.16% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 10.46% |
| EPS Growth Forecast (3Y) | 20.18% |
Stock Splits
The last stock split was on June 10, 2004. It was a forward split with a ratio of 3.000003.
| Last Split Date | Jun 10, 2004 |
| Split Type | Forward |
| Split Ratio | 3.000003 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |